{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:53:05Z","timestamp":1782125585974,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jbo.2022.100458","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T19:10:21Z","timestamp":1666984221000},"page":"100458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["EFEMP1 binds to STEAP1 to promote osteosarcoma proliferation and invasion via the Wnt\/\u03b2-catenin and TGF-\u03b2\/Smad2\/3 signal pathways"],"prefix":"10.1016","volume":"37","author":[{"given":"Dong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianlei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7554-9087","authenticated-orcid":false,"given":"Songgang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.jbo.2022.100458_b0005","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra2103423","article-title":"New Horizons in the Treatment of Osteosarcoma","volume":"385","author":"Longo","year":"2021","journal-title":"N. Engl. J. Med.."},{"issue":"18","key":"10.1016\/j.jbo.2022.100458_b0010","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.3390\/ijms21186885","article-title":"Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies","volume":"21","author":"Lilienthal","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.jbo.2022.100458_b0015","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.3390\/cancers13122878","article-title":"Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies","volume":"13","author":"Hattinger","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"25","key":"10.1016\/j.jbo.2022.100458_b0020","doi-asserted-by":"crossref","first-page":"14523","DOI":"10.1073\/pnas.96.25.14523","article-title":"STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors","volume":"96","author":"Hubert","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.jbo.2022.100458_b0025","article-title":"Regulatory Roles of Six-Transmembrane Epithelial Antigen of the Prostate Family Members in the Occurrence and Development of Malignant Tumors","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"Pt A","key":"10.1016\/j.jbo.2022.100458_b0030","article-title":"Predictive potential of STEAP family for survival, immune microenvironment and therapy response in glioma","volume":"101","author":"Zhao","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.jbo.2022.100458_b0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00418-020-01877-7","article-title":"Six-transmembrane epithelial antigen of the prostate 1 expression promotes ovarian cancer metastasis by aiding progression of epithelial-to-mesenchymal transition","volume":"154","author":"Jiao","year":"2020","journal-title":"Histochem. Cell Biol."},{"issue":"24","key":"10.1016\/j.jbo.2022.100458_b0040","doi-asserted-by":"crossref","first-page":"14217","DOI":"10.1111\/jcmm.16038","article-title":"A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"6","key":"10.1016\/j.jbo.2022.100458_b0045","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3390\/cells10061300","article-title":"Identification of a New Transcriptional Co-Regulator of STEAP1 in Ewing's Sarcoma","volume":"10","author":"Markey","year":"2021","journal-title":"Cells."},{"issue":"36","key":"10.1016\/j.jbo.2022.100458_b0050","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1200\/JCO.19.00646","article-title":"Phase I Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate Cancer","volume":"37","author":"Danila","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.jbo.2022.100458_b0055","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2967\/jnumed.118.222844","article-title":"Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody","volume":"60","author":"Carrasquillo","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.jbo.2022.100458_b0060","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1038\/s41598-017-06353-2","article-title":"Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt\/\u03b2-catenin signaling pathway","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jbo.2022.100458_b0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","article-title":"Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy","volume":"21","author":"Peng","year":"2022","journal-title":"Mol Cancer."},{"key":"10.1016\/j.jbo.2022.100458_b0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fonc.2018.00133","article-title":"Transforming Growth Factor-\u03b2 Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment","volume":"8","author":"Verrecchia","year":"2018","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.jbo.2022.100458_b0075","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/ijms22041551","article-title":"Treating Prostate Cancer by Antibody-Drug Conjugates","volume":"22","author":"Rosellini","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jbo.2022.100458_b0080","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1158\/1078-0432.CCR-21-1483","article-title":"Novel Redirected T-Cell Immunotherapies for Advanced Prostate Cancer","volume":"28","author":"Dorff","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.jbo.2022.100458_b0085","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/vaccines9070786","article-title":"Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer","volume":"9","author":"Guo","year":"2021","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.jbo.2022.100458_b0090","first-page":"1","article-title":"The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis","volume":"2022","author":"Zhao","year":"2022","journal-title":"Oxid Med Cell Longev."},{"issue":"7","key":"10.1016\/j.jbo.2022.100458_b0095","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3390\/cells9071581","article-title":"MHC Class I-Restricted TCR-Transgenic CD4+ T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo","volume":"9","author":"Schober","year":"2020","journal-title":"Cells."},{"issue":"9","key":"10.1016\/j.jbo.2022.100458_b0100","doi-asserted-by":"crossref","first-page":"e003114","DOI":"10.1136\/jitc-2021-003114","article-title":"Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy","volume":"9","author":"Lin","year":"2021","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.jbo.2022.100458_b0105","doi-asserted-by":"crossref","first-page":"9578484","DOI":"10.1155\/2020\/9578484","article-title":"The Tumor Suppressive Roles and Prognostic Values of STEAP Family Members in Breast Cancer","volume":"2020","author":"Wu","year":"2020","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.jbo.2022.100458_b0110","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.clbc.2018.08.010","article-title":"STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession","volume":"19","author":"Xie","year":"2019","journal-title":"Clin Breast Cancer."},{"issue":"7","key":"10.1016\/j.jbo.2022.100458_b0115","doi-asserted-by":"crossref","first-page":"11172","DOI":"10.1002\/jcb.28393","article-title":"Six-transmembrane epithelial antigen of the prostate 1 is associated with tumor invasion and migration in endometrial carcinomas","volume":"120","author":"Sun","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"30","key":"10.1016\/j.jbo.2022.100458_b0120","doi-asserted-by":"crossref","first-page":"47938","DOI":"10.18632\/oncotarget.10296","article-title":"EFEMP1 promotes ovarian cancer cell growth, invasion and metastasis via activated the AKT pathway","volume":"7","author":"Yin","year":"2016","journal-title":"Oncotarget."},{"issue":"4","key":"10.1016\/j.jbo.2022.100458_b0125","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/1078-0432.CCR-17-1628","article-title":"Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma","volume":"24","author":"Nandhu","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.jbo.2022.100458_b0130","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/cas.14300","article-title":"Dual antivascular function of human fibulin-3 variant, a potential new drug discovery strategy for glioblastoma","volume":"111","author":"Ke","year":"2020","journal-title":"Cancer Sci."},{"issue":"45","key":"10.1016\/j.jbo.2022.100458_b0135","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1038\/onc.2015.13","article-title":"Fibulin-3 is a novel TGF-\u03b2 pathway inhibitor in the breast cancer microenvironment","volume":"34","author":"Tian","year":"2015","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.jbo.2022.100458_b0140","doi-asserted-by":"crossref","first-page":"e67458","DOI":"10.1371\/journal.pone.0067458","article-title":"Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS ONE"},{"issue":"18","key":"10.1016\/j.jbo.2022.100458_b0145","doi-asserted-by":"crossref","first-page":"25712","DOI":"10.18632\/oncotarget.8263","article-title":"EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition via Wnt\/\u03b2-catenin signaling in endometrial carcinoma","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget."},{"issue":"12","key":"10.1016\/j.jbo.2022.100458_b0150","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1515\/BC.2009.140","article-title":"EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells","volume":"390","author":"Camaj","year":"2009","journal-title":"Biol. Chem."},{"issue":"34","key":"10.1016\/j.jbo.2022.100458_b0155","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1038\/onc.2017.109","article-title":"Tumor-derived fibulin-3 activates pro-invasive NF-\u03baB signaling in glioblastoma cells and their microenvironment","volume":"36","author":"Nandhu","year":"2017","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.jbo.2022.100458_b0160","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1158\/0008-5472.CAN-12-1060","article-title":"Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling","volume":"72","author":"Hu","year":"2012","journal-title":"Cancer Res."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137422000483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137422000483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:19:23Z","timestamp":1761941963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137422000483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":32,"alternative-id":["S2212137422000483"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2022.100458","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EFEMP1 binds to STEAP1 to promote osteosarcoma proliferation and invasion via the Wnt\/\u03b2-catenin and TGF-\u03b2\/Smad2\/3 signal pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2022.100458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100458"}}